Stock Rich List
Nasdaq: ELVN

Enliven Therapeutics insiders

The officers, directors and 10% owners of Enliven Therapeutics, Inc. who hold the most stock, valued at the live ELVN price.

$46.41
ELVN today +$1.5M (+3.39%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
11
Their ELVN stock
$713M
Market value
$3.42B
Held by ranked insiders
20.9%

Insiders by value of ELVN holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Nea 14 Gp, LTD10% owner3,538,940$164M4.81%Corporate
2New Enterprise Associates 14, L.P.10% owner3,305,601$153M4.49%Corporate
3NEA Partners 14, L.P.10% owner2,611,050$121M3.55%Corporate
4Mark ChinDirector2,344,072$109M3.19%1385th
5Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICER1,751,596$81.3M2.38%1765th
6Samuel KintzPRESIDENT AND CEO890,392$41.3M1.21%2926th
7Anish PatelCHIEF OPERATING OFFICER235,011$10.9M0.32%8208th
8Braden M Leonard10% owner230,000$10.7M0.31%7717th
9David M. MottDirector229,224$10.6M0.31%4905th
10Richard A. HeymanDirector146,320$6.8M0.20%9780th
11Jake BauerDirector87,372$4.1M0.12%13857th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Enliven Therapeutics; see each profile for the filing.